SARS-CoV-2 infection after vaccination in patients with inflammatory rheumatic and musculoskeletal diseases

被引：28

作者：

Lawson-Tovey, Saskia ^{[1
,2
]}

Hyrich, Kimme L. ^{[2
,3
]}

Gossec, Laure ^{[4
,5
]}

Strangfeld, Anja ^{[6
]}

Carmona, Loreto ^{[7
]}

Raffeiner, Bernd ^{[8
]}

Yardimci, Gozde Kubra ^{[9
]}

Trefond, Ludovic ^{[10
]}

Roux, Nicolas ^{[11
]}

Rodrigues, Ana ^{[12
,13
]}

Papagoras, Charalampos ^{[14
]}

Mateus, Elsa F. ^{[15
,16
]}

Mariette, Xavier ^{[17
]}

Machado, Pedro M. ^{[18
,19
,20
,21
]}

机构：

[1] Univ Manchester, Ctr Genet & Genom Versus Arthrit, Ctr Musculoskeletal Res, Manchester, Lancs, England

[2] Manchester Acad Hlth Sci Ctr, Natl Inst Hlth Res, Manchester Biomed Res Ctr, Manchester, Lancs, England

[3] Univ Manchester, Ctr Epidemiol Versus Arthrit, Ctr Musculoskeletal Res, Manchester, Lancs, England

[4] Sorbonne Univ, Inst Pierre Louis Epidemiol & Sante Publ, INSERM, Paris, France

[5] Sorbonne Univ, Pitie Salpetriere Hosp, AP HP, Rheumatol Dept, Paris, France

[6] German Rheumatism Res Ctr DRFZ Berlin, Epidemiol Unit, Berlin, Germany

[7] Inst Salud Musculoesquelet INMUSC, Madrid, Spain

[8] Cent Hosp Bolzano, Dept Rheumatol, Bolzano, Italy

[9] Hacettepe Univ, Fac Med, Dept Internal Med, Div Rheumatol, Ankara, Turkey

[10] Univ Clermont Auvergne, CHU Clermont Ferrand, Serv Med Interne, Hop Gabriel Montpied,Inserm,U1071,INRA USC2018,M2, Clermont Ferrand, France

[11] Hop Robert Schuman, Serv Rhumatol, Metz, France

[12] Soc Portuguesa Reumatol, Reuma Pt, Lisbon, Portugal

[13] Nova Med Sch, CEDOC, EpiDoC Unit, CHRC Campus, Lisbon, Portugal

[14] Democritus Univ Thrace, Univ Hosp Alexandroupolis, Dept Internal Med 1, Alexandroupolis, Greece

[15] Portuguese League Rheumat Dis LPCDR, Lisbon, Portugal

[16] European League Rheumatism, Standing Comm People Arthrit Rheumatism Europe PA, Zurich, Switzerland

[17] Univ Paris Saclay, Dept Rheumatol, Hop Bicetre, AP HP, Le Kremlin Bicetre, France

[18] UCL, Ctr Rheumatol, London WC1E 6BT, England

[19] UCL, Dept Neuromuscular Dis, London WC1E 6BT, England

[20] Univ Coll London Hosp NHS Fdn Trust, Natl Inst Hlth Res NIHR, Univ Coll London Hosp Biomed Res Ctr, London, England

[21] London North West Univ Healthcare NHS Trust, Dept Rheumatol, Northwick Pk Hosp, London, England

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷 / 01期

关键词：

COVID-19; vaccination; epidemiology;

D O I：

10.1136/annrheumdis-2021-221217

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：145 / 150

页数：6

共 50 条

[1] Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations
Kroon, Feline P. B.
Najm, Aurelie
Alunno, Alessia
Schoones, Jan W.
Landewe, Robert B. M.
Machado, Pedro M.
Navarro-Compan, Victoria
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (03) : 422 - 432
[2] Safety of the first dose of mRNA SARS-CoV-2 vaccines in patients with rheumatic and musculoskeletal diseases
Connolly, Caoilfhionn M.
Ruddy, Jake A.
Boyarsky, Brian J.
Avery, Robin K.
Werbel, William A.
Segev, Dorry L.
Garonzik-Wang, Jacqueline
Paik, Julie J.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (08) : 1100 - 1101
[3] Vaccination against SARS-CoV-2 in patients with rheumatic diseases: doubts and perspectives
Benucci, M.
Infantino, M.
Marotto, D.
Ardizzone, S.
Manfredi, M.
Sarzi-Puttini, P.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (01) : 196 - 202
[4] Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines
Schulze-Koops, Hendrik
Specker, Christof
Skapenko, Alla
RMD OPEN, 2021, 7 (01):
[5] SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists
不详
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (07) : 953 - 954
[6] Risk factors for SARS-CoV-2 infection in patients with rheumatic diseases
Snarska, Weronika
Jurkowska, Zuzanna
Bobrowska-Snarska, Danuta
Brzosko, Marek
Przepiera-Bedzak, Hanna
POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2021, 131 (12):
[7] Impact of hydroxychloroquine used as DMARD on SARS-CoV-2 tests and infection evolution in a population of 871 patients with inflammatory rheumatic and musculoskeletal diseases
Trefond, Ludovic
Drumez, Elodie
Andre, Marc
Costedoat-Chalumeau, Nathalie
Seror, Raphaele
Devaux, Mathilde
Dernis, Emmanuelle
Dieudonne, Yannick
Mahou, Soumaya El
Lanteri, Aurelia
Melki, Isabelle
Queyrel, Viviane
Roumier, Mathilde
Schmidt, Jean
Barnetche, Thomas
Thomas, Thierry
Cacoub, Patrice
Belot, Alexandre
Aumaitre, Olivier
Richez, Christophe
Hachulla, Eric
JOINT BONE SPINE, 2021, 88 (06)
[8] Impact of vaccination on postacute sequelae of SARS CoV-2 infection in patients with rheumatic diseases
Patel, Naomi J.
Cook, Claire
Vanni, Kathleen
Fu, Xiaoqing
Wang, Xiaosong
Kawano, Yumeko
Qian, Grace
Hang, Buuthien
Srivatsan, Shruthi
Banasiak, Emily P.
Kowalski, Emily
Bade, Katarina
Zhang, Yuqing
Sparks, Jeffrey A.
Wallace, Zachary S. S.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (04) : 565 - 573
[9] SARS-CoV-2 vaccination willingness and predictors in patients with chronic inflammatory rheumatic diseases (CIRD) and without CIRD
Roman, Iulia
Andreica, Ioana
Baraliakos, Xenofon
Redeker, Imke
Kiltz, Uta
Braun, Juergen
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2022, 14
[10] Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases
Boyarsky, Brian J.
Ruddy, Jake A.
Connolly, Caoilfhionn M.
Ou, Michael T.
Werbel, William A.
Garonzik-Wang, Jacqueline M.
Segev, Dorry L.
Paik, Julie J.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (08) : 1098 - 1099

← 1 2 3 4 5 →